GlaxoSmithKline
This article was originally published in The Tan Sheet
Executive Summary
U.S. Consumer Healthcare business considering expansion of Kennedy Twp., Penn. facilities near Pittsburgh or relocation. Firm says SmithKline Beecham/Glaxo Wellcome merger, subsequent Block Drug acquisition are driving need for more office space. GSK previously said it would close three former Block manufacturing sites in Puerto Rico, UK, Ireland over next two years and incorporate operations into GSK facilities (1"The Tan Sheet" June 25, In Brief)